NASDAQ · Healthcare · Biotechnology
LENZ Therapeutics, Inc.
LENZ
LENZ Therapeutics, Inc. CEO Evert Schimmelpennink · Market cap $248.6M.
$7.93
+0.02 · +0.25%
52w hi $50.4052w lo $6.83
Off 52w high 81.4%
87
STRONG
Current InsiderScore
Corp · 90d
3
3 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
5
2 strong · 3 notable
Analyst consensus
Strong Buy
Avg PT $56.00
Section 01
Recent Form 4 filings
23 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Mar 27 | Evert B. Schimmelpennink | President, CEO and Secretary | Buy | 28,089 | $8.95 | +$251K | 87 |
| Mar 27 | Daniel R. Chevallard | Chief Financial Officer | Buy | 7,500 | $8.57 | +$64K | 81 |
| Mar 27 | Jeffrey P. George | Buy | 5,592 | $8.92 | +$50K | 73 | |
| Nov 07 | Daniel R. Chevallard | Chief Financial Officer | Buy | 2,178 | $22.76 | +$50K | 64 |
| Nov 07 | James W Mccollum | Buy | 10,500 | $22.79 | +$239K | 63 | |
| Sep 30 | Versant Venture Capital VI, L.P. | Sell | 57,502 | $46.41 | −$2.67M | 29 | |
| Sep 30 | Versant Venture Capital VI, L.P. | Sell | 83,066 | $46.41 | −$3.85M | 29 | |
| Sep 30 | Versant Venture Capital VI, L.P. | Sell | 49,701 | $45.35 | −$2.25M | 26 | |
| Sep 30 | Versant Venture Capital VI, L.P. | Sell | 34,405 | $45.35 | −$1.56M | 26 | |
| Sep 18 | Versant Venture Capital VI, L.P. | Sell | 49,479 | $41.59 | −$2.06M | 26 | |
| Sep 18 | Versant Venture Capital VI, L.P. | Sell | 24,370 | $41.59 | −$1.01M | 26 | |
| Sep 18 | Versant Venture Capital VI, L.P. | Sell | 40,907 | $43.00 | −$1.76M | 26 | |
| Aug 26 | Versant Venture Capital VI, L.P. | Sell | 43,978 | $38.97 | −$1.71M | 26 | |
| Aug 25 | Versant Venture Capital VI, L.P. | Sell | 50,270 | $39.53 | −$1.99M | 26 | |
| Aug 18 | Versant Venture Capital VI, L.P. | Sell | 30,628 | $38.56 | −$1.18M | 26 | |
| Aug 15 | Versant Venture Capital VI, L.P. | Sell | 145,051 | $39.50 | −$5.73M | 32 | |
| Aug 15 | Versant Venture Capital VI, L.P. | Sell | 69,949 | $39.50 | −$2.76M | 29 | |
| Jul 10 | Versant Venture Capital VI, L.P. | Sell | 191,376 | $34.00 | −$6.51M | 35 | |
| Jun 27 | Versant Venture Capital VI, L.P. | Sell | 200,000 | $30.46 | −$6.09M | 35 | |
| Jun 20 | Versant Venture Capital VI, L.P. | Sell | 100,877 | $30.35 | −$3.06M | 29 | |
| Jun 20 | Versant Venture Capital VI, L.P. | Sell | 133,924 | $30.25 | −$4.05M | 29 | |
| Jun 18 | Versant Venture Capital VI, L.P. | Sell | 100,000 | $29.95 | −$3.00M | 29 | |
| Jun 10 | Versant Venture Capital VI, L.P. | Sell | 350,000 | $29.00 | −$10.15M | 35 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JunJulAugSepOctNovDecJanFebMarAprMay